Transitional cell carcinoma (TCC), also known as urothelial carcinoma, is a malignant tumor of the urinary bladder that affects both dogs and cats. This aggressive tumor can lead to partial or complete obstruction of urination and is challenging to diagnose due to its similarity in symptoms with other urinary conditions. Understanding the diagnostic process and available treatment options is crucial for managing TCC in pets.
Why "Transitional Cell Carcinoma"?
The term "transitional cell carcinoma" refers to the type of cells lining the urinary bladder, known as transitional epithelial cells. These cells protect the body from urine's caustic effects while accommodating the bladder's stretching and distending functions. TCC specifically arises from these transitional epithelial cells.
Causes and Risk Factors
The exact causes of TCC are largely unknown, but repeated exposure to carcinogens in urine is suspected to play a significant role. Certain factors, such as exposure to phenoxy herbicide-treated lawns, breed predisposition (e.g., Shetland sheepdogs, West Highland White terriers, Beagles, Scottish terriers), urban living, and obesity, have been associated with an increased risk. Female dogs tend to be more susceptible, possibly due to less frequent urine marking, while male cats are at higher risk than females.
Diagnosis: Step-by-Step Process
- Urinalysis and Culture: Initially, a urinalysis and culture are performed to rule out common causes like bladder infections. About 30% of TCCs shed tumor cells into urine, which may be detected in the analysis.
- Imaging (Radiography and Ultrasound): If infection is ruled out, imaging methods like radiography and ultrasound help detect bladder stones or tumors. Ultrasound, particularly, allows visualization of soft tissues like tumors, aiding in diagnosis.
- Specific Imaging (Contrast Radiography, Cystoscopy): Contrast radiography with special dyes and cystoscopy (using a tiny camera to view and biopsy the bladder) is used to see inside the bladder and confirm the presence of tumors.
- Genetic Testing (BRAF Mutation Test): A non-invasive test for dogs, detecting a specific BRAF mutation, can identify TCC early. Cats do not have this option, but alternative tests may be available.
Treatment Options
1. Surgical Options
- Partial Removal of Bladder: If the tumor is small, a part of the bladder might be removed. However, recurrence is common.
- Complete Removal of Bladder: A radical option, but it leads to incontinence, requiring specialized care.
2. Medical Treatment
- NSAIDs (Piroxicam, Deracoxib): NSAIDs have shown anti-carcinoma activity and can be used alone or with other treatments.
- Chemotherapy (Mitoxantrone, Carboplatin, Gemcitabine): Various drug combinations can provide relief and extend survival, especially when used in conjunction with NSAIDs.
3. Radiation Therapy
Advanced techniques with 3D imaging allow targeted radiation, improving outcomes. However, specialized facilities are necessary.
4. Other Palliative Options
- Permanent Urinary Catheter: Allows controlled urination but increases infection risk.
- Urethral Stenting: Metal stents can help urine passage through the tumor, but incontinence is common.
- Laser Ablation: Vaporizes tumors with a surgical laser, but it's more suitable for females.
Prognosis and Considerations
Survival times depend on the tumor stage and the extent of spread. Surgical options provide relief but come with challenges like incontinence. Medical treatments, especially chemotherapy combined with NSAIDs, have shown promising results, providing both symptom relief and extended survival. Veterinary consultation is vital for personalized treatment plans tailored to each pet's specific condition.
Don't have a vet in your area yet? We can help you find a local veterinarian.
If you have more questions, the GeniusVets Telehealth platform will give you unlimited access to text and/or video calls with board-certified veterinarians! To learn more click here.